Boston Scientific CorporationBSX
NYSE•Healthcare•Medical Devices
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $20.61B, growing 17.4% year-over-year. TTM net income stood at $3.56B (75.8% growth). Quarterly EBITDA was $1.45B and operating income was $1.10B. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze BSX growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters